Kodu・Aktsiate loetelu・CorMedix Inc

CorMedix Inc

Suletud

SektorTervishoid

8.2 5.53

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

7.75

Max

8.2

Põhinäitajad
By Trading Economics
Sissetulek	25M 39M
Müük	-1.2M 127M
P/E Sektori keskmine	3.89 62.58
Aktsiakasum	0.35
Kasumimarginaal	30.293
Töötajad	191
EBITDA	-289K 66M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+79.95% upside

Dividendid
By Acuity
Järgmine tulemuste avaldamine	6. aug 2026

Turustatistika
By TradingEconomics
Turukapital	9.5M 610M
Eelmine avamishind	2.67
Eelmine sulgemishind	8.2

Uudiste sentiment

By Acuity

72%

28%

307 / 340 Pingereas Healthcare

CorMedix Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

21. juuli 2026, 19:31 UTC

CorMedix Inc. shares are higher today, reflecting strong buying activity. The stock has gained momentum since Monday's close, despite remaining below its 20-day moving average.

20. juuli 2026, 22:01 UTC

CorMedix Inc shares are higher in after-market trading, reflecting a notable rise since Monday's close, despite being below its 20-day moving average.

Võrdlus sarnastega

Hinnamuutus

CorMedix Inc Prognoos

Hinnasiht

By TipRanks

79.95% tõus

12 kuu keskmine prognoos

Keskmine 14 USD 79.95%

Kõrge 15 USD

Madal 13 USD

Põhineb 5 Wall Streeti analüütiku instrumendi CorMedix Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

5 ratings

Osta

Hoia

Müü

Põhineb 5 analüütiku instrumendi CorMedix Inc aktsia reitingul - viimase 3 kuu andmed.

Sentiment

By Acuity

307 / 340 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest CorMedix Inc

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.